Composition: Each uncoated dispersible tablet contains: Montelukast Sodium IP equivalent to Montelukast 4 mg. Levocetirizine Dihydrochloride IP 2.5 mg.
This product will have minimum 3 months expiry at the time of order dispatch
Dosage: As directed by the Dermatologist.
Colour: Quinoline Yellow WS.
Storage Instructions: Keep in a cool, dry place.
Manufactured/Marketed by: Micro Labs Limited
Schedule H drug - Warning: To be sold by retail on the prescription of a registered medical practitioner only.
Directions for use: Disperse one tablet in 5 ml (one teaspoonful) of water before administration.
